Literature DB >> 18768321

New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines.

Laïla El Kihel1, Monique Clément, Marc-Antoine Bazin, Géraldine Descamps, Mohamed Khalid, Sylvain Rault.   

Abstract

Six new synthetic bile acid derivatives were synthesized and tested in vitro against various human cancer cells (glioblastoma multiforme (GBM), multiple myeloma (KMS-11), and colonic carcinoma (HCT-116) cell lines. The best activity was obtained with compound IIIb on multiple myeloma cells (LD(50): 8.5+/-0.5 microM). This activity was associated with Mcl-1 and PARP-1 cleavage, inhibition of NFkappaB signaling, and DNA fragmentation, demonstrating an apoptotic cell death signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768321     DOI: 10.1016/j.bmc.2008.07.046

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor.

Authors:  Massimiliano Tognolini; Matteo Incerti; Iftiin Hassan-Mohamed; Carmine Giorgio; Simonetta Russo; Renato Bruni; Barbara Lelli; Luisa Bracci; Roberta Noberini; Elena B Pasquale; Elisabetta Barocelli; Paola Vicini; Marco Mor; Alessio Lodola
Journal:  ChemMedChem       Date:  2012-04-23       Impact factor: 3.466

2.  Cytotoxicity on human cancer cells of ophidiacerebrosides isolated from the African starfish Narcissia canariensis.

Authors:  Fereshteh Farokhi; Gaetane Wielgosz-Collin; Monique Clement; Jean-Michel Kornprobst; Gilles Barnathan
Journal:  Mar Drugs       Date:  2010-12-22       Impact factor: 5.118

Review 3.  Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review.

Authors:  Jung Yoon Jang; Eunok Im; Yung Hyun Choi; Nam Deuk Kim
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.